Table 4.
Any financial burden | P | |
---|---|---|
OR (95% CI) | ||
Age at LILAC participation (per year) | 0.93 (0.90, 0.95) | <0.001 |
Time since diagnosis (per year) | 0.92 (0.89, 0.95) | 0.002 |
Chemotherapy | ||
No | 1.00 | 0.005 |
Yes | 1.45 (1.12, 1.88) | |
Race/ethnicity | ||
White | 1.00 | 0.001 |
African‐American | 2.06 (1.39, 3.06) | |
Other | 0.95 (0.56, 1.61) | |
Household income at baseline | ||
<$20 000 | 1.00 | 0.009 |
$20 000‐34 999 | 0.62 (0.40, 0.94) | |
$35 000‐49 999 | 0.68 (0.45, 1.03) | |
$50 000‐74 999 | 0.56 (0.37, 0.84) | |
$75 000+ | 0.48 (0.31, 0.72) | |
Modified Charlson score | ||
0 | 1.00 | 0.002 |
1 | 1.12 (0.85, 1.47) | |
2+ | 1.59 (1.23, 2.06) | |
Stage at diagnosis | ||
Localized | 1.00 | 0.048 |
Regional | 1.40 (1.05, 1.85) | |
Distant | 1.38 (0.93, 2.07) | |
Insurance status at diagnosis | ||
Public only | 1.00 | <0.001 |
None | 2.28 (0.93, 5.62) | |
Private only | 0.62 (0.40, 0.97) | |
VA | 0.26 (0.12, 0.60) | |
Public and private | 0.53 (0.35, 0.79) |
CI, confidence interval; LILAC, Life and Longevity After Cancer; OR, odds ratio; VA, United States Department of Veterans Affairs